A Phase III Clinical Trial of Duloxetine in Participants With Fibromyalgia
Phase 3
- Conditions
- Fibromyalgia
- Registration Number
- JPRN-jRCT2080221737
- Lead Sponsor
- SHIONOGI & CO., LTD.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Participants fulfilling the criteria in the American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. And et al.
Exclusion Criteria
Participants with past history of multiple episodes of drug allergy.
Participants previously treated with duloxetine.
And et al.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change from baseline in Brief Pain Inventory (BPI)-average pain score
- Secondary Outcome Measures
Name Time Method